Publications by authors named "Prexy Modi"

Claim this Profile
C
Changes in Bcl-2 Family Protein Profile During Idelalisib Therapy Mimic Those During Duvelisib Therapy in Chronic Lymphocytic Leukemia Lymphocytes.
Qingshan Yang, Prexy Modi, Anil Korkut, Stacey M Fernandes, John Hanna

JCO Precis Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells.
Prexy Modi, Kumudha Balakrishnan, Qingshan Yang, William G Wierda, Michael J Keating

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma.
Qingshan Yang, Prexy Modi, Terry Newcomb, Christophe Quéva, Varsha Gandhi

Clin Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis